Molecular Oncology Almanac
  • API
  • Approvals
  • Organizations
  • About
  • Contact
  • News

  1. Therapies
  2. tx:ncit:C769

Prednisolone

About

Therapy type: Chemotherapy

Therapy strategy: Corticosteroid

Mappings

NCI Thesaurus: Prednisolone (coding:ncit:C769)

RxNorm: prednisolone (coding:rxcui:8638, coding:omop:4020623)

SNOMED: Prednisolone (coding:sctid:116601002, coding:omop:1550557)

View API

Therapeutic response

Precision oncology relationships for therapeutic response involving this therapy.

Organizations Biomarkers Cancer types Therapies
FDA (1) BRCA1 oncogenic variants Prostate Adenocarcinoma Abiraterone acetate, Olaparib, Prednisolone
FDA (1) BRCA1 pathogenic variants Prostate Adenocarcinoma Abiraterone acetate, Olaparib, Prednisolone
FDA (1) BRCA2 oncogenic variants Prostate Adenocarcinoma Abiraterone acetate, Olaparib, Prednisolone
FDA (1) BRCA2 pathogenic variants Prostate Adenocarcinoma Abiraterone acetate, Olaparib, Prednisolone
FDA (1) CD20 + Non-Hodgkin Lymphoma Cyclophosphamide, Prednisolone, Rituximab, Vincristine
EMA (1) FDA (1) CD20 + Non-Hodgkin Lymphoma Cyclophosphamide, Doxorubicin, Prednisolone, Rituximab, Vincristine
EMA (2) BRCA1 oncogenic variants Prostate Adenocarcinoma Abiraterone acetate, Niraparib, Prednisolone
EMA (2) BRCA2 oncogenic variants Prostate Adenocarcinoma Abiraterone acetate, Niraparib, Prednisolone
EMA (2) BRCA1 pathogenic variants Prostate Adenocarcinoma Abiraterone acetate, Niraparib, Prednisolone
EMA (2) BRCA2 pathogenic variants Prostate Adenocarcinoma Abiraterone acetate, Niraparib, Prednisolone

Please review our privacy policy and terms before use.
API | Bluesky | Changelog | Contact | LinkedIn | News

  • Dana-Farber logo